CT Biphasic with Contrast at Chughtai Lab

Understanding CT Biphasic with Contrast at Chughtai Lab

A CT Biphasic with Contrast is a highly specialized, non-invasive diagnostic imaging procedure that plays a pivotal role in modern medicine, particularly in the evaluation of abdominal organs. This advanced computed tomography scan is designed to capture detailed cross-sectional images of the body during two distinct phases of contrast enhancement: the arterial phase and the portal venous phase. By utilizing state-of-the-art multi-slice CT scanners at Chughtai Lab, this examination provides exceptional anatomical detail, allowing radiologists to differentiate between various types of tissues, blood vessels, and pathological lesions. The clinical importance of a biphasic CT scan lies in its unique ability to exploit the dual blood supply of the liver, making it the gold standard for detecting, characterizing, and monitoring hepatic tumors, vascular abnormalities, and complex abdominal conditions.

The liver is unique because it receives its blood supply from two sources: the hepatic artery (approximately 25%) and the portal vein (approximately 75%). Normal liver tissue enhances primarily during the portal venous phase, whereas primary liver tumors, such as hepatocellular carcinoma (HCC), and hypervascular metastases derive almost all of their blood supply from the hepatic artery. By administering an intravenous iodinated contrast agent and scanning at precise time intervals, a CT Biphasic with Contrast captures the ‘wash-in’ of contrast during the late arterial phase (when the tumor lights up) and the ‘wash-out’ during the portal venous phase (when the tumor appears darker than the surrounding normal liver tissue). This physiological difference is crucial for accurate diagnosis, treatment planning, and monitoring therapeutic response, offering patients in Pakistan access to international-standard diagnostic accuracy.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the safety, efficacy, and diagnostic quality of a CT Biphasic with Contrast at Chughtai Lab. Patients are advised to adhere to the following guidelines prior to their scheduled appointment:

• Fasting Requirements: Patients must fast (avoid solid foods and liquids other than water) for at least 4 to 6 hours before the scan. This minimizes the risk of nausea or vomiting, which can sometimes be triggered by the intravenous contrast medium, and ensures optimal visualization of the abdominal structures.
• Renal Function Assessment: Because the iodinated contrast agent is excreted through the kidneys, patients must provide a recent Serum Creatinine and estimated Glomerular Filtration Rate (eGFR) report (usually within the last 30 days). This is a vital safety measure to rule out pre-existing renal impairment.
• Allergy History: Patients must inform the medical staff of any history of allergies, particularly to iodine, seafood, or previous contrast media. If a mild allergy exists, a pre-medication protocol involving corticosteroids and antihistamines may be prescribed by the physician.
• Medication Review: Patients taking metformin for diabetes must discuss this with their physician, as they may need to temporarily suspend the medication for 48 hours after the contrast administration to prevent lactic acidosis.
• Hydration: Unless medically contraindicated (such as in severe heart or kidney failure), patients should drink plenty of water before and after the procedure to help flush the contrast dye out of their system.
• Clothing and Valuables: Patients should wear loose, comfortable clothing and avoid wearing jewelry, metal zippers, or underwire bras, as metal can interfere with the CT imaging process.

During the Procedure

The CT Biphasic with Contrast procedure is structured to maximize patient safety and comfort while maintaining high diagnostic precision:

• Patient Positioning: The patient is asked to lie flat on their back (supine position) on the motorized CT scanner table. Straps and pillows may be used to help maintain the correct position and keep the patient still during the scan.
• Intravenous Access: A qualified nurse or technologist will insert an intravenous (IV) cannula, typically in a large vein in the antecubital fossa of the arm. This cannula is connected to an automated dual-head power injector, which delivers the iodinated contrast agent at a precise flow rate.
• Contrast Administration: As the contrast dye is injected, patients commonly experience a warm, flushing sensation throughout their body, a metallic taste in their mouth, or a transient feeling of needing to urinate. These are completely normal, harmless side effects that subside within a couple of minutes.
• The Scanning Process: The motorized table will slide slowly through the circular opening of the CT gantry. The scanner uses a rotating X-ray tube and advanced detectors to acquire images. The system is programmed to take images at two precise intervals: the arterial phase (approximately 25 to 35 seconds post-injection) and the portal venous phase (approximately 60 to 70 seconds post-injection).
• Breath-Holding Instructions: To prevent motion blur on the images, the patient will be instructed to hold their breath for a few seconds during each scanning phase. Cooperation is vital for obtaining high-resolution, diagnostic-quality images.
• Duration and Safety: The actual scanning process takes less than a minute, though the entire procedure, including preparation and IV placement, takes about 15 to 20 minutes. Throughout the scan, the technologist monitors the patient from an adjacent control room through a glass window and an intercom system.

When is a CT Biphasic with Contrast Performed?

Evaluation of Focal Liver Lesions

Physicians frequently request a CT Biphasic with Contrast when routine ultrasound or blood tests suggest the presence of a focal liver lesion. Patients presenting with symptoms such as right upper quadrant abdominal pain, unexplained weight loss, or early satiety require this specialized imaging to differentiate between benign lesions (like hemangiomas, focal nodular hyperplasia, or adenomas) and malignant tumors. The biphasic contrast timing allows radiologists to analyze the vascular enhancement patterns of the lesion, which is key to establishing a definitive diagnosis without the immediate need for an invasive biopsy.

Screening and Monitoring of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma is a primary liver cancer that commonly develops in patients with chronic liver diseases, such as Hepatitis B, Hepatitis C, or liver cirrhosis. Clinical guidelines recommend regular surveillance for these high-risk patients. When screening tests like serum Alpha-Fetoprotein (AFP) levels are elevated or an ultrasound reveals a suspicious nodule, a biphasic CT scan is performed. It assists physicians by confirming the diagnosis of HCC based on its classic hypervascular arterial enhancement and subsequent venous washout, and it helps in staging the disease for treatment selection.

Assessment of Hepatic Metastases

For patients diagnosed with primary cancers of the gastrointestinal tract, breast, lung, or neuroendocrine system, the liver is a common site for metastatic spread. A CT Biphasic with Contrast is highly sensitive in detecting both hypervascular and hypovascular metastatic lesions. Oncologists rely on this scan to determine the extent of metastatic disease, plan surgical resections, evaluate the feasibility of local therapies (such as radiofrequency ablation or transarterial chemoembolization), and monitor the patient’s response to systemic chemotherapy.

Pre-operative Planning for Liver Resection or Transplantation

Prior to undergoing major hepatobiliary surgery, such as a partial hepatectomy or a liver transplant, surgeons require a detailed anatomical map of the patient’s liver. A biphasic CT scan provides precise visualization of the hepatic arterial anatomy, portal venous system, and hepatic veins. This detailed vascular mapping helps surgeons identify anatomical variants, assess tumor proximity to major blood vessels, calculate future liver remnant volume, and plan a safe surgical approach to minimize intraoperative complications.

Investigation of Portal Vein Thrombosis and Vascular Anomalies

Patients with portal hypertension, liver cirrhosis, or hypercoagulable states are at risk of developing portal vein thrombosis (blood clots in the portal vein). Symptoms may include sudden abdominal pain, ascites, or gastrointestinal bleeding. A CT Biphasic with Contrast is performed to evaluate the patency of the portal vein and its branches. The portal venous phase of the scan clearly demonstrates filling defects within the portal vein, evaluates the presence of cavernous transformation, and identifies portosystemic collateral pathways (varices) that could lead to life-threatening hemorrhages.

What Does a CT Biphasic with Contrast Detect?

A CT Biphasic with Contrast is an exceptionally detailed imaging modality capable of detecting a wide range of pathological conditions within the abdomen, with a primary focus on the hepatobiliary and vascular systems. The scan is highly effective at identifying:

• Hepatocellular Carcinoma (HCC): Characterized by intense, heterogeneous enhancement during the arterial phase and rapid washout during the portal venous phase.
• Hepatic Hemangiomas: Common benign liver tumors showing peripheral nodular enhancement during the arterial phase with progressive centripetal fill-in during the venous phase.
• Focal Nodular Hyperplasia (FNH): A benign lesion exhibiting rapid, uniform arterial enhancement, often with a non-enhancing central scar.
• Hepatic Adenomas: Benign epithelial liver tumors associated with oral contraceptive use, showing early arterial enhancement and variable venous phase appearance.
• Hypervascular Liver Metastases: Secondary tumors (e.g., from neuroendocrine tumors or renal cell carcinoma) that enhance brightly during the arterial phase.
• Hypovascular Liver Metastases: Secondary tumors (e.g., from colorectal cancer) that appear as hypoattenuating lesions during the portal venous phase.
• Portal Vein Thrombosis: Complete or partial blood clots within the portal vein, visible as filling defects during the venous phase.
• Hepatic Artery Stenosis or Aneurysm: Narrowing or abnormal ballooning of the hepatic artery, clearly mapped during the arterial phase.
• Liver Cirrhosis: Morphological changes such as nodular liver contours, hypertrophy of the caudate lobe, and atrophy of the right lobe.
• Splenomegaly: Enlargement of the spleen, often secondary to portal hypertension or hematological disorders.
• Portosystemic Collaterals (Varices): Dilated, tortuous veins in the gastroesophageal, splenorenal, or umbilical regions due to portal hypertension.
• Ascites: Pathological accumulation of free fluid within the peritoneal cavity.
• Hepatic Cysts: Well-defined, non-enhancing fluid-filled lesions within the liver parenchyma.
• Liver Abscesses: Infectious fluid collections, often showing a ‘double-target’ sign with peripheral rim enhancement.
• Hepatic Steatosis (Fatty Liver): Diffuse or focal reduction in liver attenuation, making the liver appear darker than the spleen.
• Budd-Chiari Syndrome: Obstruction of the hepatic venous outflow, characterized by hepatomegaly, ascites, and altered hepatic enhancement.
• Gallbladder Calculi (Gallstones): Calcified or non-calcified stones within the gallbladder lumen.
• Cholecystitis: Inflammation of the gallbladder wall, indicated by wall thickening, mucosal enhancement, and pericholecystic fluid.
• Biliary Tract Dilatation: Widening of the intrahepatic or extrahepatic bile ducts due to obstruction (e.g., stones, strictures, or tumors).
• Pancreatic Masses: Tumors of the pancreas, which may show differential enhancement compared to normal pancreatic parenchyma.
• Acute or Chronic Pancreatitis: Inflammatory changes, parenchymal necrosis, peripancreatic fluid collections, or calcifications.
• Renal Masses or Cysts: Solid or cystic lesions within the kidneys, evaluated for enhancement characteristics.
• Abdominal Lymphadenopathy: Enlarged lymph nodes in the retroperitoneum, mesenteric, or portal regions, indicative of infection, lymphoma, or metastasis.
• Abdominal Aortic Aneurysm (AAA): Abnormal dilation of the abdominal aorta, assessed for size, thrombus, or rupture risk.
• Splenic Infarction: Wedge-shaped, non-enhancing areas in the spleen due to arterial occlusion.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized across Pakistan for its commitment to providing timely, accurate, and highly reliable diagnostic reports. After the completion of your CT Biphasic with Contrast scan, the raw volumetric data is processed to generate high-resolution multiplanar reconstructions. A Consultant Radiologist specializing in abdominal imaging carefully reviews the images, compares them with any available clinical history or previous scans, and drafts a comprehensive diagnostic report.

The finalized report, along with high-quality digital images, is typically available within 24 to 48 hours. Chughtai Lab offers multiple convenient ways for patients to access their results. Patients can download their reports directly from the official Chughtai Lab website or through the Chughtai Healthcare mobile application. Additionally, reports can be received via WhatsApp or collected in person from any of the convenient Chughtai Lab diagnostic centers located throughout major cities, including Lahore, Karachi, Islamabad, and Peshawar.

CT Biphasic with Contrast Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hepatic Parenchyma	Homogeneous attenuation, smooth outer contours, normal size.	Cirrhotic nodularity, fatty infiltration, diffuse parenchymal heterogeneity.
Hepatic Arterial Phase	Normal caliber and course of hepatic arteries; no early enhancing lesions.	Hypervascular lesions (HCC, FNH, adenoma, hypervascular metastases), arterial aneurysms.
Portal Venous Phase	Homogeneous enhancement of liver tissue; patent portal and hepatic veins.	Hypovascular metastases, washout of arterial lesions, portal vein thrombosis, Budd-Chiari syndrome.
Biliary System	No intrahepatic or extrahepatic biliary ductal dilatation; normal gallbladder.	Choledocholithiasis, cholecystitis, biliary strictures, cholangiocarcinoma.
Spleen	Normal size (craniocaudal length < 12 cm), homogeneous enhancement.	Splenomegaly, splenic infarcts, focal splenic lesions, accessory spleen.
Pancreas	Normal size, lobulated contour, homogeneous parenchymal enhancement.	Pancreatic adenocarcinoma, acute/chronic pancreatitis, pseudocysts, neuroendocrine tumors.
Vascular Structures	Normal caliber of abdominal aorta and inferior vena cava; no thrombus.	Abdominal aortic aneurysm, IVC thrombosis, portosystemic collateral varices.
Peritoneal Cavity	No free fluid, gas, or pathological lymphadenopathy.	Ascites, hemoperitoneum, loculated abscesses, retroperitoneal lymphadenopathy.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for CT Biphasic with Contrast?

• Experienced Healthcare Professionals: Scans are interpreted by highly qualified Consultant Radiologists with specialized training in abdominal and vascular imaging.
• Patient-Focused Care: Dedicated staff members guide patients through every step of the procedure, ensuring comfort, safety, and clear communication.
• Quality Diagnostic Services: Chughtai Lab adheres to strict international quality control standards, ensuring high diagnostic accuracy and reproducibility.
• Modern Diagnostic Approach: Utilization of advanced multi-slice CT technology minimizes scan times and radiation exposure while maximizing image resolution.
• Professional Reporting: Detailed, structured reports provide clear answers to referring physicians, facilitating prompt clinical decision-making.
• Comfortable Environment: State-of-the-art diagnostic centers designed to provide a clean, safe, and stress-free experience for all patients.
• Convenient Location: An extensive network of diagnostic centers across Pakistan makes it easy for patients to access services close to home.
• Commitment to Accurate Diagnosis: Continuous investment in advanced medical technology and staff training to maintain the highest clinical standards.